APA Style
Ahmed, D, M. (2018).
Treatment outcome of combination therapy of Pegylated interferon-α2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks in HCV Genotype 3 chronic hepatitis and compensated cirrhosis patients .
BSMMU:
Dr. Mainuddin Ahmed.
MLA Style
Ahmed, Dr., Mainuddin.
"Treatment outcome of combination therapy of Pegylated interferon-α2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks in HCV Genotype 3 chronic hepatitis and compensated cirrhosis patients".
BSMMU:
Dr. Mainuddin Ahmed,
2018.
Thesis.